In pediatric advanced life support (PALS), when is atropine indicated and what is the recommended dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Atropine Use in Pediatric Advanced Life Support (PALS)

In PALS, atropine is indicated specifically for symptomatic bradycardia caused by increased vagal tone or AV block (not due to hypoxia), with a dose of 0.02 mg/kg IV/IO, minimum 0.1 mg, maximum 0.5 mg for children or 1.0 mg for adolescents, repeated every 5 minutes up to a total of 1 mg (child) or 2 mg (adolescent). 1, 2

Primary Indications

Atropine has limited and specific roles in PALS:

1. Symptomatic Bradycardia with Cardiopulmonary Compromise

  • Use atropine ONLY when bradycardia is due to increased vagal tone or AV conduction block 2
  • Do NOT use atropine as first-line for hypoxia-induced bradycardia - oxygenation and ventilation are essential first maneuvers 1
  • Epinephrine is the drug of choice if oxygen and adequate ventilation fail to correct hypoxia-induced bradycardia 1

2. Specific Clinical Algorithm for Bradycardia Management

Step 1: Identify bradycardia (HR <60/min) with cardiopulmonary compromise (altered mental status, hypotension, shock)

Step 2: Immediately optimize oxygenation and ventilation - this is the PRIMARY intervention 2

Step 3: Determine the cause:

  • If hypoxia, hypotension, hypothermia, hypoglycemia, acidosis, or toxic ingestion → Continue supportive care, give epinephrine 0.01 mg/kg IV/IO 2
  • If increased vagal tone or AV block (not hypoxia-related) → Atropine is indicated 2

Step 4: If bradycardia persists despite correction of reversible causes → Start CPR if HR remains <60/min with poor perfusion 2

Dosing Specifications

Standard Bradycardia Dosing

  • IV/IO: 0.02 mg/kg 1
  • Minimum single dose: 0.1 mg 1
  • Maximum single dose: 0.5 mg (child), 1.0 mg (adolescent) 1
  • Repeat: Every 5 minutes to maximum total of 1 mg (child) or 2 mg (adolescent) 1

Alternative Routes (Less Preferred)

  • IM: 0.02-0.04 mg/kg 1
  • Endotracheal: Neonates 0.01-0.03 mg/kg; Children/adolescents 0.03-0.06 mg/kg (followed by saline flush) 1

Special Circumstances

Anticholinesterase/Nerve Gas Poisoning:

  • 0.05 mg/kg IV (up to 2-5 mg initial adult dose)
  • May double dose and repeat every 10-20 minutes to achieve atropinization 1

RSI Premedication (Controversial - See Below):

  • 0.01-0.02 mg/kg IV/IO (minimum 0.1 mg, maximum 1 mg) before sedative/paralytic agents 1

Critical Pitfalls and Caveats

Common Mistake #1: Using Atropine for Hypoxic Bradycardia

Atropine is NOT indicated for bradycardia due to hypoxia. The 2025 AHA/AAP guidelines explicitly state atropine is only for bradycardia "due to increased vagal tone or atrioventricular conduction block not due to factors such as hypoxia" 2. Epinephrine is the appropriate drug after ensuring adequate ventilation and oxygenation 2.

Common Mistake #2: Routine Use During Emergency Intubation

The 2025 guidelines downgraded atropine premedication for intubation from previous recommendations 2, 3. Current evidence:

  • No longer routinely recommended for emergency intubation premedication 4, 2
  • May be reasonable only when higher risk of bradycardia exists (e.g., when using succinylcholine) 4
  • Recent studies show low incidence of bradycardia (4.8%) during pediatric RSI, with no difference whether atropine was given or not 5
  • If used for RSI premedication: 0.02 mg/kg with no minimum dose required 4, 2

Common Mistake #3: Minimum Dose Confusion

The historical 0.1 mg minimum dose requirement has been challenged. The 2015 guidelines noted this was based on weak evidence from only 5 pediatric patients in a 1971 study 4. More recent evidence shows 0.02 mg/kg without a minimum dose is effective and does not cause paradoxical bradycardia 4, 2, 6. However, for bradycardia treatment (not RSI premedication), the 0.1 mg minimum remains in current guidelines 1, 2.

Common Mistake #4: Using Atropine in Cardiac Arrest

There is insufficient evidence to support routine use of atropine for pediatric cardiac arrest 7. It should not be part of the standard cardiac arrest algorithm.

Evidence Quality and Nuances

The recommendations are based primarily on Class I, Level C-LD evidence from the 2025 AHA/AAP guidelines 2, representing the most recent and authoritative source. Key points:

  • Atropine increases heart rate in both children and adults, but its use is mechanistically limited to vagolytic indications 2
  • No randomized trials demonstrate that atropine improves survival or prevents cardiac arrest 4
  • The shift away from routine RSI premedication reflects accumulating observational data showing low bradycardia incidence and lack of benefit 5
  • Different atropine concentrations exist in clinical practice - calculate dosage accordingly to avoid errors 1

Drug Preparation Notes

  • Atropine sulfate comes in different concentrations - verify before administration 1
  • For neonates, only the 0.5 mEq/mL concentration should be used (this applies to sodium bicarbonate, but highlights the importance of concentration awareness) 1
  • Each vial is single-dose only - discard unused portions 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.